¿Û¿Û´«Ã½

Why ‘market moments’ never matter

The Squeeze: Focusing on a single issue can blind investors in the long term

Will this industrial giant be more attractive after a split?

Activist who campaigned for Honeywell’s break-up expects its parts to be worth much more than its whole

A French pharma group rediscovering its joie de vivre

The company’s turnaround progress is slow but will reward patient investors

McDonald’s beats expectations as sales hold up

The company’s strong performance came while its fast food rivals have struggled

Why pharma stocks are a smarter AI play

Pharma’s AI investment fits far better into the industry’s business model

The best US banking stocks

The Analyst: Robin Hardy outlines the best options in a booming sector

Investors need to be wary of Palantir

The Squeeze: The company thinks it’s at the forefront of innovation, but it’s cutting R&D spending

Fund managers' favourite international shares

Find out which stocks top fund managers think are the best in the world

Why the market sell-off is about more than just software

There has been a rotation towards ‘real-world’ stocks as investors look to hide from AI disruption

Amazon announces huge capex increase

Despite increasing profits, its free cash flow could turn negative this year